Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Creative Edge Nutrition Inc FITX

Creative Edge Nutrition, Inc. is a nutrition company. The Company is engaged in the development, marketing and sales of nutraceuticals and health supplements. The Company develops, manufactures, markets, distributes, brands and private labels health supplements, energy and fitness products, and bottled water products for the United States and International markets. The Company is involved in... see more

GREY:FITX - Post Discussion

Creative Edge Nutrition Inc > The whole thing just get sbetter....
View:
Post by TechDrive on Feb 24, 2015 3:38pm

The whole thing just get sbetter....

FITX still trying pass off the federal government basically telling them to GET LOST you will never receive a license into some twisted sort of positive thing to try and jack the stock so they can dump more...ridiculous, the entire fiaso is laughable.


Creative Edge gets refusal notice from Health Canada 2015-02-23 19:36 ET - News Release An anonymous director reports
STATEMENT FROM HEALTH CANADA

It has come to Health Canada's attention that Creative Edge Nutrition Inc. (CEN Biotech Inc.) issued a Feb. 19, 2015, shareholder update statement, which mischaracterizes the meaning of the department's recent action in respect of the application for a licence to produce under the marihuana for medical purposes regulations. On Feb. 13, 2015, Health Canada sent a notice of intent to refuse to CEN Biotech in response to the licence application. The MMPR requires that Health Canada give notice to any applicant to which it intends to refuse a licence. The applicant is provided 20 days to provide written representations. It is in the public interest to clarify Health Canada's actions on this matter.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities